KBLB - Kraig Biocraft Laboratories, Inc


0.0882
0.002   2.494%

Share volume: 1,198,357
Last Updated: 04-28-2025
Chemicals/Plastic Material & Synthetic Resin/Rubber: 0.03%

PREVIOUS CLOSE
CHG
CHG%

$0.09
0.00
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
31%
Profitability 35%
Dept financing 43%
Liquidity 11%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
2.56%
1 Month
-2.65%
3 Months
-7.06%
6 Months
-9.07%
1 Year
-9.07%
2 Year
-9.07%
Key data
Stock price
$0.09
P/E Ratio 
0.00
DAY RANGE
$0.08 - $0.09
EPS 
$0.00
52 WEEK RANGE
$0.07 - $0.11
52 WEEK CHANGE
-$9.07
MARKET CAP 
96.361 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$623,246
AVERAGE 30 VOLUME 
$529,131
Company detail
CEO: Kim K. Thompson
Region: US
Website: kraiglabs.com
Employees: 8
IPO year: 2010
Issue type:
Market: OTCM
Industry: Chemicals/Plastic Material & Synthetic Resin/Rubber
Sector: Manufacturing

Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology. Its products are used in military and police applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components. The company was incorporated in 2006 and is headquartered in Michigan.

Recent news

Kraig Biocraft Laboratories Provides Production Update on Recombinant Spider Silk Operations

ANN ARBOR, Mich., April 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, is pleased to provide an update on recombinant spider silk production. The Company continues to increase its production output and is now in the middle of its largest-ever batch of recombinant spider silk production. Kraig Labs can now report that it has successfully completed the first half of its current production batc

Read more

Kraig Biocraft Laboratories Announces the Launch of Advanced Gene-Splicing Program and New Transgenics

Company Adopting Advanced Gene Editing Platform Across All Commercial Silkworm Development ProgramsANN ARBOR, Mich., April 15, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology1, today announced the successful rollout of a next-generation molecular biology and gene-splicing platform. This powerful new system represents a major leap forward in the Company's ability to create and refine genetically enginee

Read more

24/7 Market News- Kraig Biocraft Laboratories Signals Acceleration: Spider Silk Is Coming

Momentum Builds as Kraig Labs Locks down Branding, Breaks Records, Scales Production, and Gains Global Attention Denver, Colorado--(Newsfile Corp. - April 10, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB) is no longer a quiet innovator—it's making moves that demand investor attention. Over the past few months, the Company has racked up a series of

Read more